Technical coding skill ('how to program') is a commodity that can be assisted by LLMs. The real value comes from 'what to program': defining the right clinical question, selecting appropriate data, and designing validation steps. This strategic layer requires deep domain expertise and cannot be fully automated.
The competitive advantage in pharma isn't the sophistication of an AI algorithm, which is often a commodity built on third-party models. The true differentiator is the quality, relevance, and end-to-end consistency of the proprietary data used to train and validate these models. Poor data invalidates even the best analytics.
Effective collaboration between physicians, data scientists, and business leaders requires a dedicated 'bridging communicator.' This person understands both clinical implications and data science requirements, translating medical needs into technical tasks and outputs into clinical insights, preventing specialists from working in isolation.
The primary obstacle preventing healthcare from using its data is not technology but the scarcity of professionals possessing deep expertise in both medicine and data science. This talent gap is the root cause of issues like data silos and complexity, as effectively working with the data requires understanding both domains.
Technologists without deep medical knowledge can unintentionally process data in ways that change its underlying biological meaning, creating data points that are physiologically impossible. This makes domain expertise critical for ensuring data integrity and the validity of AI-driven conclusions in healthcare.
Unlike controlled clinical trial data, real-world evidence is derived from vast, messy, and incomplete data from daily healthcare. This variability is its strength, offering deeper insights into long-term outcomes, drug interactions, and diverse patient populations that clean trial data misses.